News & Events
MS organisations and health professionals gather in Dubai for MENACTRIMS 2017
More than 900 health professionals and representatives from 38 countries gathered in Dubai for MENACTRIMS 2017, which…
2017: a pivotal year for the MSIF movement
This year marked the 50th anniversary of the MS International Federation, giving us a valuable opportunity to…
Study shows taking MS medications as directed is better for overall health
Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health
New study shows cold water in the mouth can reduce heat sensitivity in MS
Cold water in the mouth can help reduce heat sensitivity, a common symptom of MS.
Disappointing results from CCSVI treatment trial
Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that…
Discovering how immune cells get into the brain in MS
Study reveals important mechanism that allows immune cells to attack myelin in MS
MS Australia publishes first report on MS Specialist Nurses in Australia
A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s…
Art University redecorates facilities of Brazilian MS Association
Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between…
Leading Belgian politician presents 2017 “MS@Work” awards
Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring…
2017 McDonald Fellowship and Du Pré grant recipients announced
MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants
Portuguese MS Society (SPEM) launches new Support Line service
New Support Line will provide information and support, as well as jobs for people living with MS
European Medicines Agency recommends market authorisation for ocrelizumab (Ocrevus) in EU
The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be…